August 24, 2023
Gateway Checker Introduces Gateway CertifiedTM Program to Support DSCSA Interoperability Requirements
Lexington, MA, August 28, 2023 – Gateway Checker, the industry’s leading GS1-certified conformance testing service, today announced the introduction of the Gateway Certification program. A “Gateway CertifiedTM” drug transaction report enables organizations to be confident that they are compliant, interoperable, and fully conform to industry and regulatory requirements. In November, all pharmaceutical trading partners will […]
August 22, 2023
Antares Vision Group, through rfxcel, Joins the Gateway Certified™ Program to Lead VRS Standardized Testing Initiative
AV Group, which led an FDA-approved pilot to extend testing of the VRS, continues its DSCSA leadership by helping to test industry readiness. TRAVAGLIATO, BRESCIA, ITALY, August 22, 2023/EINPresswire.com/ — Antares Vision Group, an Italian multinational and a leading provider of track and trace and quality control systems, today announced that it has joined the […]
May 1, 2023
Blue Link Partners with Gateway Checker to Help Pharma Distributors Meet DSCSA Interoperability Deadline
Blue Link Associates and Gateway Checker are pleased to announce a new partnership that will help increase the security and stability of the pharmaceutical supply chain by providing robust software solutions to pharmaceutical wholesale and distribution customers.
July 6, 2022
FDA recommends EPCIS for DSCSA Drug Traceability
Happy Independence Day! After many years of uncertainty, FDA has (finally!) recommended that trading partners use the Electronic Product Code Information Services (EPCIS) standard to provide and maintain the data associated with transaction information and transaction statements. Prior regulations and guidance were less specific; only mandating that standards of interoperable exchange “shall comply with a […]
June 5, 2021
Getting Ready: Drug Traceability
Published June 5th, 2021 As the community prepares for the GS1 Connect 2021: Digital Edition conference next week, the FDA issued new guidance to further enhance the security of prescription drugs in the supply chain. This guidance is intended to assist trading partners in complying with the law and achieving a safer, more secure, and […]
